Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 106 to 119 of 119 results for osteoarthritis

  1. Artificial metacarpophalangeal and interphalangeal joint replacement for end-stage arthritis (IPG110)

    Evidence-based recommendations on artificial metacarpophalangeal and interphalangeal joint replacement for end-stage arthritis. This involves removing the diseased joints and replacing them with artificial ones.

    Interventional procedures guidance
    Published
    23 February 2005
    View recommendations

    Sections for IPG110

  2. Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis (IPG111)

    Evidence-based recommendations on artificial trapeziometacarpal joint replacement for treating end-stage osteoarthritis. This involves replacing the arthritic joint at the base of the thumb with an artificial joint.

    Interventional procedures guidance
    Published
    23 February 2005
    View recommendations

    Sections for IPG111

  3. Cox-II inhibitors for the treatment of osteoarthritis and rheumatoid arthritis (TA27)

    This guidance has been replaced by NICE guideline CG59 and NICE guideline CG79.

    Technology appraisal guidance
    Published
    23 July 2001

  4. Total hip arthroplasty using the superpath approach for osteoarthritis

    In development [GID-IPG10204] Expected publication date: TBC

    Interventional procedures guidance
    In development

  5. Cox-II inhibitors for the treatment of osteoarthritis and rheumatoid arthritis [ID388]

    Discontinued [GID-TAG372]

    Technology appraisal guidance
    Discontinued

  6. Tanezumab for treating moderate to severe chronic pain caused by osteoarthritis [ID1603]

    Discontinued [GID-TA10711]

    Technology appraisal guidance
    Discontinued

  7. Osteoarthritis - naproxcinod [ID417]

    Discontinued [GID-TAG426]

    Technology appraisal guidance
    Discontinued

  8. Osteoarthritis - diacerein [ID332]

    Discontinued [GID-TAG250]

    Technology appraisal guidance
    Discontinued

  9. Tanezumab for treating pain caused by bone metastases [ID3784]

    Discontinued [GID-TA10922]

    Technology appraisal guidance
    Discontinued

  10. Arthrosamid for symptomatic treatment of knee osteoarthritis

      Status ...

    Medical technologies guidance
    Topic selection

  11. High tibial osteotomy with adjustable magnetic nail insertion for symptomatic medial knee osteoarthritis

    Discontinued [GID-IPG10142]

    Interventional procedures guidance
    Discontinued

  12. Insertion of a synthetic cartilage for first CMC osteoarthritis

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  13. Radiofrequency denervation for OA shoulder pain

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  14. Digital platforms for community based self-management of mild to moderate osteoarthritis and joint pain

    Awaiting development [GID-MT610] Expected publication date: TBC

    Medical technologies guidance
    Awaiting development